Rheumatology/Arthritis Market Research Reports & Industry Analysis
Some evidence suggests that excessive immune responses may be due to glucocorticoid resistance in target tissues. For example, the number of glucocorticoid receptors in circulating leukocytes is decreased 50% in patients with RA. This decrease in receptors would prevent adequate suppression of leukocyte activity and could further enhance inflammation.Rheumatologists remain the most up-to-date health professionals in autoimmune disease treatment. Early intervention has been noted by nearly all in the field as the single most important factor in treatments and continued quality of life. New advancements in risk factors, diagnosis, and therapies have made it possible for rheumatologist to treat these conditions successfully with the best possible outcomes.
Successful treatment of autoimmune diseases have resulted from a growing array of therapies available to specialists. Symptomatic treatments have traditionally been used for patients with rheumatoid arthritis, lupus and other autoimmune disorders. While these treatments are still used regularly, new disease-modifying therapies have produced the most impressive results in treating these diseases. Additionally, combination therapies continue to grow in preference and offer exciting results in disease management.
Rheumatology/Arthritis Industry Research & Market Reports
-
Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2030
... Spain, and the United Kingdom), and Japan. Rheumatoid Arthritis (RA) Understanding Rheumatoid Arthritis Overview Rheumatoid arthritis (RA) is an autoimmune or chronic inflammatory disease that is known to impact the joints of the body adversely. ... Read More
-
Rheumatoid Arthritis - Market Insights, Epidemiology and Market Forecast - 2030
... States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The RA market report provides current treatment practices, emerging drugs, RA market share of the individual therapies, current and forecasted RA market size ... Read More
-
Musculoskeletal Disorders Drugs Investment Global Outlook 2020
... due to disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 outbreak.. The market is then expected to recover and grow at a CAGR of ... Read More
-
Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types, Distribution Channels, Company Analysis
... works as the injection which is given at the accurate depth and through which patients feels comfortable comparing to manual syringes. As the autoinjector is a modern developed device, so they are more preferred over ... Read More
-
Rheumatoid Arthritis - Pipeline Review, H2 2020
... landscape. Rheumatoid arthritis (RA) is an autoimmune chronic disorder that eventually leads to destruction of bones causing deformities. Signs and symptoms of rheumatoid arthritis include tender, warm, swollen joints, fatigue, and fever and weight loss. ... Read More
-
Global Penicillamine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
... growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. ... Read More
-
Rheumatoid Arthritis Drugs Market- Growth, Trends, and Forecast (2020 - 2025)
... an increase in the acceptance of biopharmaceuticals. The major factors that fuel the growth of the market are the growing burden of rheumatoid arthritis disease with the increasing geriatric population. It usually affects the geriatric ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2020: Covid 19 Impact and Recovery
... CAGR of -1.22%, this is due to disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 outbreak.. The market is then expected to recover and ... Read More
-
Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User (Hospitals, Clinical Labs) – Global Forecast to 2025
... autoimmune disease diagnosis market size is projected to register a CAGR of 8.9% during the forecast period.” The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD ... Read More
-
Hydroxychloroquine Market, By Disease Indication (Malaria, Coronavirus Disease, Lupus Erythematosus, and Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin Am
... East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 Hydroxychlorquine has exhibits the potential invitro activity against viruses including influenza, malaria, coronavirus, and many other diseases. The drug is under investigation ... Read More
-
Europe Anti-rheumatics Market Forecast 2020-2028
... a large geriatric population, is one of the crucial factors favoring the market growth in the region. MARKET INSIGHTS The Europe anti-rheumatics market is researched further by segmenting the region into countries such as France, ... Read More
-
Asia Pacific Anti-rheumatic Market Forecast 2020-2028
... rise in awareness related to the use of anti-rheumatics, are boosting the growth of the market in the region. MARKET INSIGHTS The Asia Pacific anti-rheumatics market is further surveyed on the basis of the markets ... Read More
-
Global Chloroquine Market 2020-2024
... reports on chloroquine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Chronic Lower Back Pain (CLBP) - Market Insight, Epidemiology and Market Forecast -2030
... back pain (CLBP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic lower back pain (CLBP) market report provides current treatment practices, emerging drugs, and market ... Read More
-
Musculoskeletal Disorders Drugs Market covering Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs; Global Summary 2019
... in 2018, accounting for 41.9% of the global musculoskeletal disorders drugs market, followed by Asia Pacific at 33.5% and Western Europe at 7.6% respectively. Musculoskeletal Disorders Drugs Global Market Summary 2019 provides strategists, marketers and ... Read More
-
Cell Therapy Market Size, Share & Trends Analysis Report By Use-type (Research, Commercialized, Musculoskeletal Disorders), By Therapy Type (Autologous, Allogeneic), By Region, And Segment Forecasts, 2020 - 2027
... is expected to reach USD 8.8 billion by 2027 at a CAGR of 5.4% over the forecast period, according to a new report by Grand View Research, Inc. Cellular therapies hold a great therapeutic promise ... Read More
-
Global Antigout Drug Market Research Report 2020-2024
... this market. Antigout Drug Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North ... Read More
-
Global Rheumatoid Arthritis Drugs Market Forecast 2020-2030
... of the forecast period. In 2018, the biologics submarket held 85% of the global Rheumatoid Arthritis market. How this report will benefit you Read on to discover how you can exploit the future business opportunities ... Read More
-
Rheumatoid Arthritis (RA) - Pipeline Insight, 2020
... Of The Rheumatoid Arthritis (RA) Pipeline Landscape Is Provided, Which Includes The Disease Overview And Rheumatoid Arthritis (RA) Treatment Guidelines. The Assessment Part Of The Report Embraces In-Depth Rheumatoid Arthritis (RA) Commercial Assessment And Clinical ... Read More
-
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2019
... summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. Products covered by Phase • Phase III, Phase II, Phase I • Pre-clinical & ... Read More
-
Rheumatoid Arthritis - Pipeline Review, H1 2020
... landscape. Rheumatoid arthritis (RA) is an autoimmune chronic disorder that eventually leads to destruction of bones causing deformities. Signs and symptoms of rheumatoid arthritis include tender, warm, swollen joints, fatigue, and fever and weight loss. ... Read More
-
Juvenile Rheumatoid Arthritis- Market Insight, Epidemiology and Market Forecast -2030
... trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Juvenile Rheumatoid Arthritis market report provides current treatment practices, emerging drugs, Juvenile Rheumatoid Arthritis market share of the individual ... Read More
-
The 2021-2026 World Outlook for Rheumatoid Arthritis Autoimmune Disorder Diagnostics
... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More
-
The 2021-2026 World Outlook for Rheumatoid Arthritis Diagnosis Tests
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2021-2026 World Outlook for Rheumatoid Arthritis (RA) Drugs
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
